Researchers are calling on an end to discriminatory health and illicit drugs policies, based on overwhelming evidence that new hepatitis C therapies are effective at

Immunotherapy may be an effective treatment for HIV-related Kaposi sarcoma (KS), according to the results of a small US study published in Cancer Immunology Research.

For the first time, a US-based professional HIV body has published guidelines endorsing event-based or so-called ‘on-demand’ pre-exposure prophylaxis (PrEP) as an alternative to daily

Having HIV is associated with a greater likelihood of cigarette smoking and using smokeless tobacco, according to research conducted in 25 sub-Saharan African countries and

The number of new tuberculosis (TB) cases continued to decline in 2017, and fewer people died from the disease, according to the World Health Organization’s

A new gold-standard triple therapy for H.I.V. has just made its debut in Africa. It costs $75 a year. In the United States, many people with

Gay men in London who source their own supply of generic pre-exposure prophylaxis (PrEP) drugs, usually from overseas internet pharmacies, most often learnt about this

The High Court has today overturned Gilead’s patent extension on Truvada, the HIV drug also used in PrEP. Deborah Gold, chief executive of NAT (National

People living with HIV are twice as likely to develop cardiovascular disease (CVD), according to the findings of a meta-analysis published in Circulation. The research

With Section 377 out and implementation of the HIV and AIDS Prevention Act, patients rights groups working on AIDS prevention this new act should become